People | January 06, 2026
Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
The FDA acknowledged that Corcept’s pivotal GRACE trial met its primary endpoint and that data from the GRADIENT trial offered confirmatory evidence
The Phase II study will assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of 9MW3811 in patients with pathological scarring
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
His professional background also includes key experience at Matrix Labs and Sun Pharma
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
The approval is supported by data from three pivotal clinical trials
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
Subscribe To Our Newsletter & Stay Updated
